Abstract
RNA-binding proteins (RBPs) and microRNAs (miRNAs) are the most important regulators of mRNA stability and translation in eukaryotic cells; however, the complex interplay between these systems is only now coming to light. RBPs and miRNAs regulate a unique set of targets in either a positive or negative manner and their regulation is mainly opposed to each other on overlap** targets. In some cases, the levels of RBPs or miRNAs regulate the cellular levels of one another and decreased levels of either results in changes in translation of their targets. There is growing evidence that these regulatory circuits are crucial in the development and progression of cancer; however, the rules underlying synergism and antagonism between miRNAs and RNA-binding proteins remain unclear. Synthetic biology seeks to develop artificial systems to better understand their natural counterparts and to develop new, useful technologies for manipulation of gene expression at the RNA level. The recent development of artificial RNA-binding proteins promises to enable a much greater understanding of the importance of the functional interactions between RNA-binding proteins and miRNAs, as well as enabling their manipulation for therapeutic purposes.
Similar content being viewed by others
References
Erson AE, Petty EM (2008) MicroRNAs in development and disease. Clin Genet 74:296–306
Cowland JB, Hother C, Gronbaek K (2007) MicroRNAs and cancer. APMIS 115:1090–1106
Lee RC (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901–906
Hammond SM (2015) An overview of microRNAs. Adv Drug Deliv Rev 87:3–14
Friedman RC, Farh KK-H, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92–105
Lee Y, Jeon K, Lee J-T et al (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21:4663–4670
Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123:631–640
Denli AM, Tops BBJ, Plasterk RH et al (2004) Processing of primary microRNAs by the microprocessor complex. Nature 432:231–235
Yi R, Qin Y, Macara IG, Cullen BR (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17:3011–3016
Lund E, Güttinger S, Calado A et al (2004) Nuclear export of microRNA precursors. Science 80(303):95–98
Kobayashi H, Tomari Y (2016) RISC assembly: coordination between small RNAs and Argonaute proteins. Biochim Biophys Acta Gene Regul Mech 1859:71–81
Iwakawa HO, Tomari Y (2015) The functions of MicroRNAs: mRNA decay and translational repression. Trends Cell Biol 25:651–665
Meister G (2013) Argonaute proteins: functional insights and emerging roles. Nat Rev Genet 14:447–459
Kim HH, Kuwano Y, Srikantan S et al (2009) HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 23:1743–1748
Epis MR, Barker A, Giles KM et al (2011) The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J Biol Chem 286:41442–41454
Chen Y, Yang F, Zubovic L et al (2016) Targeted inhibition of oncogenic miR-21 maturation with designed RNA-binding proteins. Nat Chem Biol 12:717–723
Kedde M, van Kouwenhove M, Zwart W et al (2010) A Pumilio-induced RNA structure switch in p27-3’ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 12:1014–1020
Liu J, Carmell MA, Rivas FV et al (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437–1441
Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379
Chen Y, Boland A, Kuzuoǧlu-Öztürk D et al (2014) A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing. Mol Cell 54:737–750
Ørom UA, Nielsen FC, Lund AH (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30:460–471
Vasudevan S, Tong Y, Steitz JA (2008) Cell cycle control of microRNA-mediated translation regulation. Cell Cycle 7:1545–1549
Gerstberger S, Hafner M, Tuschl T (2014) A census of human RNA-binding proteins. Nat Rev Genet 15:829–845
Lunde BM, Moore C, Varani G (2007) RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 8:479–490
Auweter SD, Oberstrass FC, Allain FHT (2006) Sequence-specific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res 34:4943–4959
Neelamraju Y, Hashemikhabir S, Janga SC (2015) The human RBPome: from genes and proteins to human disease. J Proteom 127:61–70
Pereira B, Billaud M, Almeida R (2017) RNA-binding proteins in cancer: old players and new actors. Trends Cancer 3:506–528
Medioni C, Mowry K, Besse F (2012) Principles and roles of mRNA localization in animal development. Development 139:3263–3276
Rackham O, Brown CM (2004) Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs. EMBO J 23:3346–3355
Treiber T, Treiber N, Plessmann U et al (2017) A compendium of RNA-binding proteins that regulate MicroRNA biogenesis. Mol Cell 66:270–284
Srikantan S, Tominaga K, Gorospe M (2012) Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci 13:372–379
Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1–12
Cho WCS (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789–799
Akao Y, Nakagawa Y, Naoe T (2006) let-7 MicroRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29:903–906
Babashah S, Soleimani M (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47:1127–1137
Meisner N-C, Filipowicz W (2011) Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 700:106–123
Young LE, Moore AE, Sokol L et al (2012) The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol Cancer Res 10:167–180
Webster RJ, Giles KM, Price KJ et al (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7. J Biol Chem 284:5731–5741
Abdelmohsen K, Kim MM, Srikantan S et al (2010) miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9:1354–1359
Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M (2008) miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci 105:20297–20302
Cimmino A, Calin GA, Fabbri M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944–13949
**g Q, Huang S, Guth S et al (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623–634
Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004
van Kouwenhove M, Kedde M, Agami R (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11:644–656
Zhang L (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103:9136–9141
Kim MS, Oh JE, Kim YR et al (2010) Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol 221:139–146
Melo SA, Moutinho C, Ropero S et al (2010) A genetic defect in exportin-5 traps precursor MicroRNAs in the nucleus of cancer cells. Cancer Cell 18:303–315
Suzuki HI, Yamagata K, Sugimoto K et al (2009) Modulation of microRNA processing by p53. Nature 460:529–533
Mori M, Triboulet R, Mohseni M et al (2014) Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156:893–906
Hebar A, Valent P, Selzer E (2013) The impact of molecular targets in cancer drug development: major hurdles and future strategies. Expert Rev Clin Pharmacol 6:23–34
Steins M, Thomas M, Geißler M (2018) Erlotinib. Recent results in cancer research. Springer, Cham, pp 1–17
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714–726
Auweter SD, Fasan R, Reymond L et al (2006) Molecular basis of RNA recognition by the human alternative splicing factor Fox-1. EMBO J 25:163–173
Oubridge C, Ito N, Evans PR et al (1994) Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature 372:432–438
Newman M, Thomson JM, Hammond SM (2008) Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14:1539–1549
Wickens M, Bernstein DS, Kimble J, Parker R (2002) A PUF family portrait: 3′UTR regulation as a way of life. Trends Genet 18:150–157
Filipovska A, Razif MFM, Nygard KKA, Rackham O (2011) A universal code for RNA recognition by PUF proteins. Nat Chem Biol 7:425–427
Filipovska A, Rackham O (2011) Designer RNA-binding proteins: new tools for manipulating the transcriptome. RNA Biol 8:978–983
Filipovska A, Rackham O (2012) Modular recognition of nucleic acids by PUF, TALE and PPR proteins. Mol Biosyst 8:699
Wang X, McLachlan J, Zamore PD, Hall TMT (2002) Modular recognition of RNA by a human Pumilio-homology domain. Cell 110:501–512
Wang Y, Wang Z, Tanaka Hall TM (2013) Engineered proteins with Pumilio/fem-3 mRNA binding factor scaffold to manipulate RNA metabolism. FEBS J 280:3755–3767
Ozawa T, Natori Y, Sato M, Umezawa Y (2007) Imaging dynamics of endogenous mitochondrial RNA in single living cells. Nat Methods 4:413–419
Yoshimura H, Ozawa T (2018) Real-time fluorescence imaging of single-molecule endogenous noncoding RNA in living cells. Humana Press, New York, pp 337–347
Yoshimura H, Inaguma A, Yamada T, Ozawa T (2012) Fluorescent probes for imaging endogenous β-actin mRNA in living cells using fluorescent protein-tagged pumilio. ACS Chem Biol 7:999–1005
Yamada T, Yoshimura H, Inaguma A, Ozawa T (2011) Visualization of nonengineered single mRNAs in living cells using genetically encoded fluorescent probes. Anal Chem 83:5708–5714
Yoshimura H, Ozawa T (2016) Monitoring of RNA dynamics in living cells using PUM-HD and fluorescent protein reconstitution technique. Methods in enzymology. Academic Press, Cambridge, pp 65–85
Cooke A, Prigge A, Opperman L, Wickens M (2011) Targeted translational regulation using the PUF protein family scaffold. TL-108. Proc Natl Acad Sci USA 108:15870–15875
Cao J, Arha M, Sudrik C et al (2015) A universal strategy for regulating mRNA translation in prokaryotic and eukaryotic cells. Nucleic Acids Res 43:4353–4362
Campbell ZT, Valley CT, Wickens M (2014) A protein-RNA specificity code enables targeted activation of an endogenous human transcript. Nat Struct Mol Biol 21:732–738
Cao J, Arha M, Sudrik C et al (2014) Bidirectional regulation of mRNA translation in mammalian cells by using PUF domains. Angew Chem Int Ed Engl 53:4900–4904
Adamala KP, Martin-Alarcon DA, Boyden ES (2016) Programmable RNA-binding protein composed of repeats of a single modular unit. Proc Natl Acad Sci USA 113:E2579–E2588
Wang Y, Cheong C-G, Hall TMT, Wang Z (2009) Engineering splicing factors with designed specificities. Nat Methods 6:825–830
Wang Y, Wang Z (2016) Design of RNA-binding proteins: manipulate alternative splicing in human cells with artificial splicing factors. In: Clifton NJ (ed) Methods in molecular biology. Humana Press, New York, pp 227–241
Coquille S, Filipovska A, Chia T et al (2014) An artificial PPR scaffold for programmable RNA recognition. Nat Commun 5:5729
Filipovska A, Rackham O (2013) Pentatricopeptide repeats. RNA Biol 10:1426–1432
Schmitz-Linneweber C, Small I (2008) Pentatricopeptide repeat proteins: a socket set for organelle gene expression. Trends Plant Sci 13:663–670
Barkan A, Rojas M, Fujii S et al (2012) A combinatorial amino acid code for RNA recognition by pentatricopeptide repeat proteins. PLoS Genet 8:4–11
Lopez Sanchez MIG, Mercer TR, Davies SMK et al (2011) RNA processing in human mitochondria. Cell Cycle 10:2904–2916
Davies SMK, Lopez Sanchez MIG, Narsai R et al (2012) MRPS27 is a pentatricopeptide repeat domain protein required for the translation of mitochondrially encoded proteins. FEBS Lett 586:3555–3561
Rackham O, Filipovska A (2012) The role of mammalian PPR domain proteins in the regulation of mitochondrial gene expression. Biochim Biophys Acta Gene Regul Mech 1819:1008–1016
Liu G, Mercer TR, Shearwood AMJ et al (2013) Map** of mitochondrial RNA-protein interactions by digital rnase footprinting. Cell Rep 5:839–848
Rackham O, Busch JD, Matic S et al (2016) Hierarchical RNA processing is required for mitochondrial ribosome assembly. Cell Rep 16:1874–1890
Siira SJ, Spåhr H, Shearwood AMJ et al (2017) LRPPRC-mediated folding of the mitochondrial transcriptome. Nat Commun 8:1532
Small ID, Rackham O, Filipovska A (2013) Organelle transcriptomes: products of a deconstructed genome. Curr Opin Microbiol 16:652–658
Spåhr H, Chia T, Lingford JP et al (2018) Modular ssDNA binding and inhibition of telomerase activity by designer PPR proteins. Nat Commun 9:2212
Cai Y, Mikkelsen JG (2016) Lentiviral delivery of proteins for genome engineering. Curr Gene Ther 16:194–206
Buchholz CJ, Friedel T, Büning H (2015) Surface-engineered viral vectors for selective and cell type-specific gene delivery. Trends Biotechnol 33:777–790
Kaczmarczyk SJ, Sitaraman K, Young HA et al (2011) Protein delivery using engineered virus-like particles. Proc Natl Acad Sci 108:16998–17003
Bolhassani A, Jafarzade BS, Mardani G (2017) In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides 87:50–63
Acknowledgements
Research in our groups has been supported by fellowships, scholarships and grants from the Australian Research Council (FT0991008, FT0991113, DP140104111 to A. F. and O. R.), the National Health and Medical Research Council (APP1058442, APP1045677 to A. F. and O. R.,APP1071081 and APP1084964 to P. L), and the Cancer Council Western Australia (to A. F. and O. R.).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vos, P.D., Leedman, P.J., Filipovska, A. et al. Modulation of miRNA function by natural and synthetic RNA-binding proteins in cancer. Cell. Mol. Life Sci. 76, 3745–3752 (2019). https://doi.org/10.1007/s00018-019-03163-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-019-03163-9